0001213900-20-016303.txt : 20200630
0001213900-20-016303.hdr.sgml : 20200630
20200630160830
ACCESSION NUMBER: 0001213900-20-016303
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190905
FILED AS OF DATE: 20200630
DATE AS OF CHANGE: 20200630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zarrabian Saiid
CENTRAL INDEX KEY: 0001495521
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37823
FILM NUMBER: 201002414
MAIL ADDRESS:
STREET 1: P.O. BOX 675765
CITY: RANCHO SANTA FE
STATE: CA
ZIP: 92067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DelMar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001498382
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 990360497
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 12707 HIGH BLUFF DR., SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 350-4364
MAIL ADDRESS:
STREET 1: 12707 HIGH BLUFF DR., SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Berry Only Inc.
DATE OF NAME CHANGE: 20100805
4
1
ownership.xml
X0306
4
2019-09-05
0
0001498382
DelMar Pharmaceuticals, Inc.
DMPI
0001495521
Zarrabian Saiid
12707 HIGH BLUFF DR., SUITE 200
SAN DIEGO
CA
92130
1
1
0
0
President and CEO
Options (Right to Buy)
0.61
2020-06-26
4
A
0
241438
0
A
2029-09-05
Common Stock
241438
457650
D
On September 5, 2019, the reporting person received options to purchase 241,438 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020.
1/6th of the options vested on March 5, 2020 with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on April 5, 2020.
/s/ Anthony Scott Praill, attorney-in-fact for Saiid Zarrabian
2020-06-30